Search Results - "Advani, S.H"

Refine Results
  1. 1
  2. 2

    Discrepancies in Epstein—Barr virus association at presentation and relapse of classical Hodgkin's disease: Impact on pathogenesis by Nerurkar, A. Y., Vijayan, P., Srinivas, V., Soman, C. S., Dinshaw, K. A., Advani, S. H., Magrath, I., Bhatia, K., Naresh, K. N.

    Published in Annals of oncology (01-04-2000)
    “…Background: Though Epstein-Barr virus (EBV) has been linked to classical Hodgkin's disease (cHD), only a proportion of cHD cases show EBV-association. While…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    191PEXPERIENCE OF ALK MUTATION TESTING IN 3351 INDIAN PATIENTS OF NSCLC by Dutt, S., Advani, S.H., Dhabhar, B.N., Dattatreya, P.S., Patil, S., Chatterjee, S., Srinivasan, S., Mishra, D.K., Raja, T., Pavithran, K., Reddy, P.V.A., Nambiar, R.G., Gaur, R.

    Published in Annals of oncology (01-09-2014)
    “…Abstract Aim: In the last decade, we have witnessed a revolution in the molecular genetics of NSCLC (Non Small Cell Lung Cancer). These advances have led to…”
    Get full text
    Journal Article
  6. 6
  7. 7

    First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study by Feher, O., Vodvarka, P., Jassem, J., Morack, G., Advani, S. H., Khoo, K. S., Doval, D. C., Ermisch, S., Roychowdhury, D., Miller, M. A., von Minckwitz, G.

    Published in Annals of oncology (01-06-2005)
    “…Background:: This randomized, phase III study compared the efficacy and safety of first-line gemcitabine versus epirubicin in the treatment of postmenopausal…”
    Get full text
    Journal Article
  8. 8

    Report of chronic myelogenous leukemia in chronic phase from, Asian Institute of Oncology, Mumbai, 2002-2010 by Bansal, Shweta, Advani, S H

    “…Chronic myeloid leukemia (CML) has paradigm shift in its treatment modality after the discovery of targeted therapy Imatinib. At our centre we collected data…”
    Get full text
    Journal Article
  9. 9

    Epstein—Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed—Sternberg cells by Naresh, K.N., Johnson, J., Srinivas, V., Soman, C.S., Saikia, T., Advani, S.H., Badwe, R.A., Dinshaw, K.A., Muckaden, M., Magrath, I., Bhatia, K.

    Published in Annals of oncology (01-01-2000)
    “…Background: Most Epstein-Barr virus (EBV) associated lymphoproliferative disorders have high proliferation indices. However, classical Hodgkin's disease (cHD)…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Alterations in the p53 Gene and the Clonal Evolution of the Blast Crisis of Chronic Myelocytic Leukemia by Ahuja, H., Bar-Eli, M., Advani, S. H., Benchimol, S., Cline, M. J.

    “…Molecular mechanisms responsible for the clinical progression of chronic myelocytic leukemia to its accelerated phase or to blast crisis have not been defined…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Circulating levels of TNFα and TNF receptor superfamily members in lymphoid neoplasia by Metkar, Sunil S., Naresh, K.N., Manna, Partha P., Srinivas, V., Advani, S.H., Nadkarni, J.J.

    Published in American journal of hematology (01-10-2000)
    “…We have correlated the serum levels of TNFα and soluble TNF receptor superfamily members with clinico‐pathologic parameters in patients of Hodgkin's disease…”
    Get full text
    Journal Article
  15. 15

    Expression of P53 and Bcl-2 Proteins in T-cell Lymphoblastic Lymphoma: Prognostic Implications by Naresh, K.N., Banavali, S.D., Bhatia, K.G., Magrath, I., Soman, C.S., Advani, S.H.

    Published in Leukemia & lymphoma (2002)
    “…In patients (pts) with non-Hodgkin's lymphoma (NHL) under 25 years, treatment with MCP-842 protocol, a short duration intense protocol, yields worse survival…”
    Get full text
    Journal Article
  16. 16

    Protein kinase C isoforms in normal and chronic myeloid leukemic neutrophils. Distinct signal for PKC α by immunodetection on PVDF membrane, decreased expression of PKC α and increased expression of PKC δ in leukemic neutrophils by Balasubramanian, N, Advani, S.H, Zingde, S.M

    Published in Leukemia research (01-07-1998)
    “…Neutrophils from patients with Chronic Myeloid Leukemia (CML) exhibit defects in several functions. They also show altered phosphorylation–dephosphorylation…”
    Get full text
    Journal Article
  17. 17

    HIGH CYTOSOLIC POOL OF p75 TNF RECEPTORS AND DELAYED SURFACE DOWNMODULATION BY MONONUCLEAR CELLS FROM NON-HODGKIN'S LYMPHOMA PATIENTS by Rathore, V.B, Advani, S.H, Nadkarni, J.J

    Published in Cytokine (Philadelphia, Pa.) (01-07-2000)
    “…Analysis of the expression of TNF-Rs on fresh peripheral blood mononuclear cells (PBMNC) by Scatchard analysis showed that Gr I (stages I and II) but not Gr II…”
    Get full text
    Journal Article
  18. 18

    Correspondence by ADVANI, S.H.

    Published in Blood (01-12-1975)
    Get full text
    Journal Article
  19. 19

    Restriction fragment length polymorphism of the L-myc oncogene in non-Hodgkin's lymphoma patients from India by Fernandez, T, Saranath, D, Advani, S.H, Deo, M.G, Soman, C.S

    Published in Cancer letters (13-03-1998)
    “…We examined 89 non-Hodgkin's lymphoma (NHL) patients of Indian origin for EcoRI restriction fragment length polymorphism (RFLP) of the L-myc gene with a view…”
    Get full text
    Journal Article
  20. 20